98%
921
2 minutes
20
Clostridium difficile infection (CDI) is one of the most common causes of healthcare-associated infections but an even bigger problem for the aging population. Advanced age leads to higher incidence, higher mortality, and higher recurrences. In our study, recently published in the Journal of Infectious Diseases, we investigated the effect of aging on CDI using a mouse model. We were able to demonstrate that aging leads to worse clinical outcomes, as well as lead to changes in microbiota composition and lower antibody production against C. difficile toxin A, but not toxin B. An association between advanced age and lower antibody production against C. difficile is a new finding which would explain the effect of aging on CDI outcome. Vancomycin, an anti-C. difficile antibiotic, led to similar changes in antibody response, suggesting a connection between microbiome and antibody response in the context of aging, which would require a much more nuanced look at the treatment of CDI.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5628656 | PMC |
http://dx.doi.org/10.1080/19490976.2017.1323616 | DOI Listing |
J Infect Dev Ctries
August 2025
Division of Infectious Disease, Department of Internal Medicine, Phramongkutklao Hospital and Phramongkutklao College of Medicine, Bangkok 10400, Thailand.
Introduction: Clostridioides difficile often causes hospital-acquired diarrhea, leading to unfavorable treatment outcomes. This study investigates CDI treatment outcomes and factors affecting severity and mortality at a university hospital in Thailand.
Methodology: A retrospective study was conducted from June 2019 to December 2021.
Curr Opin Infect Dis
September 2025
Department of Microbiology, Royal Melbourne Hospital.
Purpose Of Review: Diagnostic stewardship (DS) aims to optimise the use of laboratory testing to improve patient care while reducing unnecessary tests. This review examines recent evidence on DS interventions to optimise the use of resources, focusing on three key areas: reducing unnecessary testing, maximising the impact of existing tests, and avoiding the overdiagnosis of hospital-acquired infections.
Recent Findings: Multiple interventions have demonstrated effectiveness in reducing unnecessary blood and urine culture testing, including clinical decision support tools, education programs, and multidisciplinary approaches.
Infect Drug Resist
August 2025
Department of Pharmacy, Mie University Hospital, Mie, Japan.
Background: The comparative effectiveness and potential impact of individual proton pump inhibitors (PPIs) on the development of infection (CDI) remain unclear. Additionally, there is insufficient evidence to support the use of probiotics for CDI prevention outside clinical trials. This study aimed to identify the PPIs that are most associated with CDI development and to determine whether probiotic co-administration can reduce this risk.
View Article and Find Full Text PDFInfect Drug Resist
September 2025
Department of Internal Medicine, Tainan Hospital, Ministry of Health and Welfare, Tainan, Taiwan.
Objective: is the most common cause of antibiotic-associated diarrhea. Wastewater from hospitals may be an important source of transmission between hospitals and communities. The objective of this study is to quantify spores and to elucidate their potential transmission risk via hospital wastewater.
View Article and Find Full Text PDFJ Biochem Mol Toxicol
September 2025
Division of Infectious Diseases and International Health, University of Virginia, Charlottesville, Virginia, USA.
Microbiota, which plays a vital role in susceptibility to Clostridioides difficile infection (CDI), synthesizes butyrate. Enteric glia is a component of the enteric nervous system (ENS) and is affected by C. difficile toxins A (TcdA) and B (TcdB).
View Article and Find Full Text PDF